These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28818358)

  • 1. Black Toenail Sign in MELAS Syndrome.
    Whitehead MT; Wien M; Lee B; Bass N; Gropman A
    Pediatr Neurol; 2017 Oct; 75():61-65. PubMed ID: 28818358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical venous disease severity in MELAS syndrome correlates with brain lesion development.
    Whitehead MT; Wien M; Lee B; Bass N; Gropman A
    Neuroradiology; 2017 Aug; 59(8):813-818. PubMed ID: 28667360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear cortical cystic lesions: Characteristic MR findings in MELAS patients.
    Ishigaki H; Sato N; Kimura Y; Takeshita E; Komaki H; Chiba E; Shigemoto Y; Goto YI; Mori-Yoshimura M; Sasaki M
    Brain Dev; 2021 Oct; 43(9):931-938. PubMed ID: 34049744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal cerebellar infarction as an initial sign of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
    Ko A; Lee SJ; Lee YM
    J Inherit Metab Dis; 2019 May; 42(3):575-576. PubMed ID: 30693531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Cortical Lesions in MELAS Syndrome: Anatomic Distribution, Symmetry, and Evolution.
    Bhatia KD; Krishnan P; Kortman H; Klostranec J; Krings T
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):167-173. PubMed ID: 31806591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive distribution of brain volume reductions in MELAS and mitochondrial DNA A3243G mutation carriers: A voxel-based morphometric study.
    Tsujikawa K; Senda J; Yasui K; Hasegawa Y; Hoshiyama M; Katsuno M; Sobue G
    Mitochondrion; 2016 Sep; 30():229-35. PubMed ID: 27558483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical, pathological and molecular biological characteristics of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episode in children].
    Liu XL; Bao XH; Ma YN; Chang XZ; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):130-5. PubMed ID: 23527980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA.
    Terauchi A; Tamagawa K; Morimatsu Y; Kobayashi M; Sano T; Yoda S
    Brain Dev; 1996; 18(3):224-9. PubMed ID: 8836506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paralytic ileus in MELAS with phenotypic features of MNGIE.
    Chang TM; Chi CS; Tsai CR; Lee HF; Li MC
    Pediatr Neurol; 2004 Nov; 31(5):374-7. PubMed ID: 15519124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes(MELAS)].
    Morita Y; Aida N
    No Shinkei Geka; 2021 Mar; 49(2):349-355. PubMed ID: 33762456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial encephalomyopathy with lactic acidosis and stroke (MELAS).
    Matsumoto J; Saver JL; Brennan KC; Ringman JM
    Rev Neurol Dis; 2005; 2(1):30-4. PubMed ID: 16400302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of stroke-like lesions in MELAS-syndrome after seizure control.
    Finsterer J; Barton P
    Epileptic Disord; 2010 Dec; 12(4):330-4. PubMed ID: 21059492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, pathologic and genetic studies on mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes.
    Guo Y; Guo Z; Chen L; Zhang J; Wang W; Liu X; Ren H; Gao S
    Chin Med J (Engl); 1997 Nov; 110(11):851-5. PubMed ID: 9772417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes: A case report.
    Bai P; Feng Y; Chen J; Chang H
    Medicine (Baltimore); 2023 May; 102(18):e33725. PubMed ID: 37144988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation.
    Tschampa HJ; Urbach H; Greschus S; Kunz WS; Kornblum C
    J Neurol; 2013 Apr; 260(4):1071-80. PubMed ID: 23196335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated thyroid peroxidase antibodies with encephalopathy in MELAS syndrome.
    Chan DW; Lim CC; Tay SK; Choong CT; Phuah HK
    Pediatr Neurol; 2007 Jun; 36(6):414-7. PubMed ID: 17560506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images.
    Tsujikawa T; Yoneda M; Shimizu Y; Uematsu H; Toyooka M; Ikawa M; Kudo T; Okazawa H; Kuriyama M; Kimura H
    Brain Dev; 2010 Feb; 32(2):143-9. PubMed ID: 19171446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR evaluation of cerebral oxygen metabolism and blood flow in stroke-like episodes of MELAS.
    Wang Z; Xiao J; Xie S; Zhao D; Liu X; Zhang J; Yuan Y; Huang Y
    J Neurol Sci; 2012 Dec; 323(1-2):173-7. PubMed ID: 23062409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome.
    Iizuka T; Sakai F; Suzuki N; Hata T; Tsukahara S; Fukuda M; Takiyama Y
    Neurology; 2002 Sep; 59(6):816-24. PubMed ID: 12297560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients.
    Kim JH; Lim MK; Jeon TY; Rha JH; Eo H; Yoo SY; Shu CH
    Korean J Radiol; 2011; 12(1):15-24. PubMed ID: 21228936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.